(R)-2-(4-Isobutylphenyl)-N-(Methylsulfonyl)Propanamide (R)-2-(4-异丁基苯基)-N-(甲基磺酰基)丙酰胺
CAS 266359-83-5 MFCD66359835
化学结构图
SMILES:
化学属性
| Mol. Weight | 289 |
|---|---|
| Mol. Formula | C14H21NO3S |
别名和识别编码
| Chemical Name Translation | (R)-2-(4-异丁基苯基)-N-(甲基磺酰基)丙酰胺 |
|---|---|
| MDL Number | |
| CAS Number | 266359-83-5 |
| Chemical Name | (R)-2-(4-Isobutylphenyl)-N-(Methylsulfonyl)Propanamide |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. Bertini R, et al. Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2non-competitive allosteric inhibitor. Br J Pharmacol. 2012 Jan;165(2):436-54.
- [3]. Kim HY, et al. Reparixin, an inhibitor of CXCR1 and CXCR2 receptor activation, attenuates blood pressure and hypertension-related mediators expression in spontaneously hypertensive rats. Biol Pharm Bull. 2011;34(1):120-7.
- [4]. Sousa LF, et al. Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in mice. Clinics (Sao Paulo). 2013;68(3):391-4.
- [5]. Bertini R, et al. Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury. Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11791-6.
- [6]. Krishnamurthy A, et al. Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediate
